TScan Therapeutics, Inc.

Q4 2025 13F Holders

Symbol
TCRX
CUSIP
89854M101
Type
Equity
Class
COM
Num filings
62
Total reported value, excl. options
$30.7 M
Manager Report Date Value ($000) Shares Option Type